SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Actavis Pharma has confirmed the continued availability of the approved brand and generically equivalent Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate (NDA020232), a 3…
# FDA Approves Organon's PROSCAR (Finasteride) for Oral Use Organon LLC received FDA approval for PROSCAR (finasteride), an oral medication that is expected to capture significant…
# FDA Approval Newswire Mylan Pharmaceuticals Inc. received FDA approval for its oral methotrexate sodium formulation (ANDA081235), expanding the company's oncology and immunology…
Actavis Pharma, Inc. has received approval for its generic version of minocycline hydrochloride (ANDA063181), a timely move that increases competition and may limit pricing pressur…
Aiping Pharm Inc secured FDA approval via this Abbreviated New Drug Application, a regulatory milestone that establishes the pathway for market distribution and generic competition…
KING PHARMS LLC has received FDA regulatory approval for NDA019901, establishing formal clearance for a new pharmaceutical entry. This development carries significant market implic…
# FDA Approves Teva Pharmaceuticals' Generic Methotrexate Oral Formulation Teva Pharmaceuticals USA, Inc. received FDA approval for its generic methotrexate sodium oral formulatio…
ALVOGEN has received FDA approval for its Abbreviated New Drug Application (ANDA063067), reinforcing the company's competitive positioning in the generic sector as the industry fac…
Hospira, Inc. received approval on June 4, 1990, for its intrathecal formulation of CYTARABINE (ANDA071868), a critical therapeutic addressing the significant unmet market demand f…
# FDA Drug Approval: TerSera Therapeutics' ZOLADEX TerSera Therapeutics LLC received FDA approval for ZOLADEX (goserelin acetate), a subcutaneous gonadotropin-releasing hormone ag…
# FDA Approval Alert AbbVie Inc.'s DEPAKOTE SPRINKLES (divalproex sodium) oral formulation received FDA approval on September 12, 1989, establishing the company's foothold in the …
# FDA Approves Pfizer Drug (NDA050639) Pfizer received FDA approval for a new drug application on August 30, 1989, expanding the company's pharmaceutical portfolio and strengtheni…
Organon announced today that the FDA has cleared the marketing of NDA019796, a decision that allows the company to expand its product portfolio and capitalize on an anticipated sur…
Strides Pharma Science Limited announced the FDA approval of its ANDA089805 for oral Acetaminophen and Codeine Phosphate, positioning the company to capture market share within the…
Strides Pharma Science Limited announced the FDA approval for Acetaminophen and Codeine Phosphate, a move anticipated to intensify competition in the combination analgesic market w…
The FDA approved Unknown Drug from ALMAJECT under application ANDA062943 on 1988-09-29.
# FDA Approves Hospira's Lidocaine Hydrochloride and Epinephrine Combination Injection Hospira, Inc. received FDA approval for its lidocaine hydrochloride and epinephrine infiltra…
# FDA Approves Hospira's Lidocaine Hydrochloride and Epinephrine for Epidural Use Hospira, Inc. has received FDA approval for its lidocaine hydrochloride and epinephrine formulati…
Hospira, Inc. confirmed the FDA's approval of its ANDA for LidoCaine Hydrochloride and Epinephrine intended for epidural administration, a product launch that is expected to expand…
# FDA Approves Harrow Eye's IOPIDINE (Apraclonidine Hydrochloride) for Ophthalmic Use Harrow Eye, LLC has received FDA approval for IOPIDINE 1% (apraclonidine hydrochloride ophtha…